Koninklijke Philips NV (PHG)
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
- Ticker
- PHG
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical Devices
- 52-week range
- $23.62 - $33.44
Valuation
- Share price
- $30.35 (close of Nov 6, 2026)
- P/E (TTM)
- 26.76x
- Price to book
- 2.28x
- Price to free cash flow
- 28.82x
Price performance
| Period | Change |
|---|---|
| 1 day | -0.52% |
| 5 days | +12.74% |
| 1 month | +25.67% |
| 3 months | +15.27% |
| 6 months | +11.46% |
| Year to date | +12.08% |
| 1 year | +7.47% |
| 3 years | +51.15% |
| 5 years | -36.40% |
| 10 years | +2.74% |
| All time | +1,328.24% |
Short interest
- As of
- Oct 15, 2026
- Short % of float
- 0.29%
- Shares short
- 2.79M
- Days to cover
- 1.96
- Change since prior report
- +7.06%
- Source
- FINRA consolidated short interest
Profitability and growth
- Return on equity
- 8.14%
- Return on invested capital
- 6.07%
- Return on assets
- 3.32%
- Return on capital employed
- 7.33%
- Gross margin
- 45.18%
- Net margin
- 5.02%
- EBITDA margin
- 14.29%
- Revenue growth
- -1.04%
- Free cash flow growth
- -27.88%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 3.47%
- Current ratio
- 1.33x
- Net debt to EBITDA
- 1.91x
Latest reported year
- Period end
- Dec 31, 2025
- Fiscal year
- 2025
- Shares outstanding
- 948.24M
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|---|---|---|---|
| 2025-12-31 | 45.18% | 5.02% | 8.14% | 6.07% |
| 2024-12-31 | 43.13% | -3.90% | -5.83% | 1.35% |
| 2023-12-31 | 40.99% | -2.56% | -3.86% | -0.30% |
| 2022-12-31 | 40.35% | -9.02% | -12.11% | -6.87% |
| 2021-12-31 | 41.78% | 19.35% | 22.93% | 2.58% |
| 2020-12-31 | 45.17% | 6.86% | 9.97% | 5.61% |
| 2019-12-31 | 46.07% | 6.81% | 9.24% | 6.16% |
| 2018-12-31 | 47.20% | 6.02% | 9.02% | 8.54% |
| 2017-12-31 | 46.01% | 9.32% | 13.82% | 7.04% |
| 2016-12-31 | 45.57% | 8.31% | 10.76% | 6.69% |
Investor relations
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|---|---|
| 2026-11-03 | Sep 2026 | - |
| 2026-07-28 | Jun 2026 | - |
| 2026-05-06 | Mar 2026 | - |
| 2025-11-04 | Sep 2025 | - |
| 2025-07-29 | Jun 2025 | - |
| 2025-05-06 | Mar 2025 | - |
| 2025-02-19 | Dec 2024 | - |
| 2024-10-28 | Sep 2024 | - |
Filings and sources
- Company website
- philips.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
Abbott Laboratories (ABT) · Medtronic plc (MDT) · Stryker Corp (SYK) · Boston Scientific Corp (BSX) · Edwards Lifesciences Corp (EW) · GE HealthCare Technologies Inc. (GEHC) · Dexcom Inc (DXCM) · STERIS plc (STE)
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades